polysaccharida haemophili influenzae typus B conjugata cum proteino neisseriae meningitidis B 53 µg corresp. polysaccharida haemophili influenzae typus B 3 µg et neisseria meningitidis B outer membrane protein complex 50 µg, hepatitidis B viri antigenum ADNr 10 µg, toxoidum pertussis 20 µg, haemagglutininum filamentosum 20 µg, pertactinum 3 µg, fimbriae Typ 2 und 3 5 µg, toxoidum diphtheriae min. 20 U.I., toxoidum tetani min. 40 U.I., virus poliomyelitis typus 1 inactivatus (Mahoney) 40 U., virus poliomyelitis typus 2 inactivatus (MEF-1) 8 U., virus poliomyelitis typus 3 inactivatus (Saukett) 32 U., aluminium ut aluminii phosphas et aluminii hydroxyphosphas sulfas amorphus, natrii phosphates, acidum hydrochloridum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.95 mg, residui: glutaralum, formaldehydum, neomycinum, streptomycinum, polymyxinum B, albuminum seri bovis, aluminii thiocyanas, faecis proteina.
Packungsbestandteile
Injection suspension
Active Agent
Dose
Haemagglutininum Filamentosum
20 µg
Hepatitidis b viri Antigenum Adnr
10 µg
Pertactin
3 µg
Polysaccharida Haemophili Influenzae Typus b Conjugata cum Proteino Neisseriae Meningitidis B
53 µg correspond Polysaccharida Haemophili Influenzae Typus B 3 µg
Toxoidum Diphtheriae
20 UI
Toxoidum Pertussis
20 µg
Toxoidum Tetani
40 UI
Virus Poliomyelitis Typus 1 Inactivatus (Mahoney)
40 U
Virus Poliomyelitis Typus 2 Inactivatus (Mef1)
8 U
Virus Poliomyelitis Typus 3 Inactivatus (Saukett)
32 U
BAG: Active Agent
Dose
Fimbriae typ 2+3
5 mcg
Haemagglutinium Filamentosum (B. Pertussis)
20 mcg
Haemophilus Influenzae b Polysaccharida (Prp)
3 mcg
Pertactinum (B. Pertussis)
3 mcg
Toxoidum Pertussis
20 mcg
Vaccinum Diphtheriae Adsorbatum
20 UI
Vaccinum Hepatitidis b (Adnr) Hbsag
10 mcg
Vaccinum Tetani Adsorbatum
40 UI
Virus Poliomyelitis Typus 1 Inactivatum (Mahoney)
40 U
Virus Poliomyelitis Typus 2 Inactivatum (Mef1)
8 U
Virus Poliomyelitis Typus 3 Inactivatum (Saukett)
32 U
Inactive agents
Dose
Acidum Hydrochloridum
Aluminii Hydroxyphosphas Sulfas Amorphus
Alumine
Fimbriae Typ
2
Natrii Phosphates
Neisseria Meningitidis b Outer Membrane Protein Complex
50 µg
Und 3
5 µg
Source
Data was imported : 06.02.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
